Hollencrest Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29K Hold
11
﹤0.01% 938
2026
Q1
$5.21K Hold
11
﹤0.01% 911
2025
Q4
$5.13K Sell
11
-50
-82% -$23.2K ﹤0.01% 908
2025
Q3
$26K Hold
61
﹤0.01% 668
2025
Q2
$23.4K Hold
61
﹤0.01% 655
2025
Q1
$21.1K Hold
61
﹤0.01% 663
2024
Q4
$18.3K Buy
61
+50
+455% +$17.5K ﹤0.01% 706
2024
Q3
$4.47K Hold
11
﹤0.01% 874
2024
Q2
$3.53K Hold
11
﹤0.01% 879
2024
Q1
$3.67K Sell
11
-2,270
-100% -$694K ﹤0.01% 842
2023
Q4
$617K Hold
2,281
0.06% 168
2023
Q3
$561K Hold
2,281
0.06% 158
2023
Q2
$692K Hold
2,281
0.07% 145
2023
Q1
$601K Buy
2,281
+2,270
+20,636% +$577K 0.06% 154
2022
Q4
$2.64K Buy
+11
New +$2.46K ﹤0.01% 913

Other funds holding HCA

Hollencrest Capital Management's HCA Position: Q2 2026 in Review

Hollencrest Capital Management held its HCA Healthcare (HCA) position steady in Q2 2026 at 11 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Hollencrest Capital Management first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $692K in Q2 2023. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Hollencrest Capital Management held 11 shares of HCA Healthcare worth $4.29K as of Q2 2026.
  • Hollencrest Capital Management left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #938 holding.
  • Hollencrest Capital Management first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's HCA Healthcare position peaked at $692K in Q2 2023.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.